Clinical reasoning engine that cuts treatment denials for health systems
Latent’s clinical reasoning engine earned them a $80M Series A this past March, co-led by Spark and Transformation Capital. They boast a 30%+ reduction in treatment denials, serve 10 out of the top 20 health systems in the US and over 2 million patients. Latent is a new entry to the Hot 25, immediately cracking the top 3! Listed on Harmonic's Hot 25 (Q4 2026 #2); best rank #2 in Q4 2026. Harmonic headcount ~125.
Healthcare
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Latent going public?
No. Latent is private and has not filed to go public. There is no S-1 on file.
What is Latent's valuation in 2026?
No confirmed valuation is on record for Latent. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Latent filed an S-1?
No public S-1 is on file for Latent.
Who are Latent's investors?
Latent's investors include Spark Capital, Transformation Capital.
Is Latent publicly traded — can you buy Latent stock?
No. Latent is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Latent on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Employees
~125
Last Round
Series A — $80M (Mar 2026)
IPO Status
private
Fundraising Status
Series A · $80M · 8 mo ago
private1 disclosed rounds
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series A
$80M
Mar 2026
—
—
Talent Signal
Hiring trend
▲ Hiring uptrend
+25% vs 2026-09
Open roles
25
via ashby
Product-build share
44%
engineering, research, product, design
Trajectory
scaling
balanced build + GTM — 44% builders vs 56% go-to-market/G&A — scaling both sides.
Executive bench growing while hiring expands: 1 senior hire (CEO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INSonal RamrakhianiCEO · 2026-09-20
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from Latent's live job board as of 2026-10-21; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Sri SomasundaramRish Jain
Investors
Spark Capital · Transformation Capital
Competitors
anterior · cohere-health
AIHealthcarePrior AuthorizationHealth Systems
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.